These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6722395)

  • 21. Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication.
    Cotes PM; Crow TJ; Johnstone EC; Bartlett W; Bourne RC
    Psychol Med; 1978 Nov; 8(4):657-65. PubMed ID: 364517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine receptor alteration in schizophrenia: neuroendocrine evidence.
    Rotrosen J; Angrist BM; Gershon S; Sachar EJ; Halpern FS
    Psychopharmacology (Berl); 1976 Dec; 51(1):1-7. PubMed ID: 827770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Aging and hormones].
    Ibayashi H
    Nihon Naibunpi Gakkai Zasshi; 1983 Nov; 59(11):1783-9. PubMed ID: 6321252
    [No Abstract]   [Full Text] [Related]  

  • 24. Prolactin and growth hormone responses to growth hormone-releasing hormone in acute schizophrenia.
    Nerozzi D; Magnani A; Sforza V; Scaramucci E; Cerilli M; Moretti C; Antonozzi I; Frajese G
    Neuropsychobiology; 1990; 23(1):15-7. PubMed ID: 2280826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia.
    Akhondzadeh S; Rezaei F; Larijani B; Nejatisafa AA; Kashani L; Abbasi SH
    Schizophr Res; 2006 Jun; 84(2-3):405-10. PubMed ID: 16545544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation by dopamine and estradiol of the central effects of angiotensin II on anterior pituitary hormone release.
    Steele MK; McCann SM; Negro-Vilar A
    Endocrinology; 1982 Sep; 111(3):722-9. PubMed ID: 7106048
    [No Abstract]   [Full Text] [Related]  

  • 27. Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics.
    Naber D; Ackenheil M; Laakman G; Fischer H; von Werder K
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):325-30. PubMed ID: 6111094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of apomorphine on schizophrenic symptoms.
    Smith RC; Tamminga C; Davis JM
    J Neural Transm; 1977; 40(2):171-6. PubMed ID: 323423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion.
    Lal S; Nair NP; Cervantes P; Pulman J; Guyda H
    Acta Psychiatr Scand; 1979 Feb; 59(2):173-9. PubMed ID: 420037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypophyseal hormonal rhythm in a physiological state].
    Copinschi G; Vanhaelst L; Robyn C; Virasoro E; Leclercq R; De Laet MH; Brion JP; L'Hermite M; Golstein J; Vekemans M; Delvoye P; Van Cauter E
    Probl Actuels Endocrinol Nutr; 1975; 19():193-208. PubMed ID: 184449
    [No Abstract]   [Full Text] [Related]  

  • 31. Growth hormone responses to graded doses of apomorphine HCl in schizophrenia.
    Cleghorn JM; Brown GM; Brown PJ; Kaplan RD; Mitton J
    Biol Psychiatry; 1983 Aug; 18(8):875-85. PubMed ID: 6137249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal effects of CV 205-502, a novel octahydrobenzo [g] quinoline with potent dopamine agonist properties.
    Gaillard RC; Brownell J
    Life Sci; 1988; 43(17):1355-62. PubMed ID: 2903425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basal and stimulated levels of prolactin, TSH, and LH in serum of chronic schizophrenic patients long-term treated with neuroleptics: relations to psychopathology.
    Naber D; Ackenheil M; Laakmann G
    Adv Biochem Psychopharmacol; 1980; 24():419-23. PubMed ID: 6105792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum.
    Lal S; De la Vega CE; Sourkes TL; Friesen HG
    J Clin Endocrinol Metab; 1973 Nov; 37(5):719-24. PubMed ID: 4749446
    [No Abstract]   [Full Text] [Related]  

  • 35. Schizophrenic symptoms improve with apomorphine.
    Tamminga CA; Schaffer MH; Smith RC; Davis JM
    Science; 1978 May; 200(4341):567-8. PubMed ID: 347574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clozapine effects on neuroendocrine response to apomorphine challenge testing in chronic neuroleptic nonresponsive schizophrenia: preliminary findings.
    Szymanski S; Lieberman J; Pollack S; Safferman A; Munne R; Umbricht D; Kane J; Kronig M; Chakos M; Cooper T
    Biol Psychiatry; 1995 Jan; 37(1):52-5. PubMed ID: 7893860
    [No Abstract]   [Full Text] [Related]  

  • 37. Longitudinal instability of hormone responses in schizophrenia.
    Cleghorn JM; Brown GM; Brown PJ; Kaplan RD; Mitton J
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):545-9. PubMed ID: 6686692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of cocaine on anterior pituitary and gonadal hormones.
    Heesch CM; Negus BH; Bost JE; Keffer JH; Snyder RW; Eichhorn EJ
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1195-200. PubMed ID: 8819502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postsynaptic supersensitivity in schizophrenia.
    Pandey GN; Garver DL; Tamminga C; Ericksen S; Ali SI; Davis JM
    Am J Psychiatry; 1977 May; 134(5):518-22. PubMed ID: 848578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroendocrine findings in the schizophrenias.
    Garver DL
    Endocrinol Metab Clin North Am; 1988 Mar; 17(1):103-9. PubMed ID: 2897906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.